1. Home
  2. ITIC vs MNMD Comparison

ITIC vs MNMD Comparison

Compare ITIC & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITIC
  • MNMD
  • Stock Information
  • Founded
  • ITIC 1972
  • MNMD 2019
  • Country
  • ITIC United States
  • MNMD United States
  • Employees
  • ITIC N/A
  • MNMD N/A
  • Industry
  • ITIC Specialty Insurers
  • MNMD Pharmaceuticals and Biotechnology
  • Sector
  • ITIC Finance
  • MNMD Health Care
  • Exchange
  • ITIC Nasdaq
  • MNMD Nasdaq
  • Market Cap
  • ITIC 440.1M
  • MNMD 509.2M
  • IPO Year
  • ITIC N/A
  • MNMD N/A
  • Fundamental
  • Price
  • ITIC $201.99
  • MNMD $8.20
  • Analyst Decision
  • ITIC
  • MNMD Strong Buy
  • Analyst Count
  • ITIC 0
  • MNMD 7
  • Target Price
  • ITIC N/A
  • MNMD $26.29
  • AVG Volume (30 Days)
  • ITIC 79.5K
  • MNMD 1.2M
  • Earning Date
  • ITIC 08-05-2025
  • MNMD 08-12-2025
  • Dividend Yield
  • ITIC 7.73%
  • MNMD N/A
  • EPS Growth
  • ITIC 18.56
  • MNMD N/A
  • EPS
  • ITIC 15.69
  • MNMD N/A
  • Revenue
  • ITIC $261,197,999.00
  • MNMD N/A
  • Revenue This Year
  • ITIC N/A
  • MNMD N/A
  • Revenue Next Year
  • ITIC N/A
  • MNMD N/A
  • P/E Ratio
  • ITIC $13.06
  • MNMD N/A
  • Revenue Growth
  • ITIC 15.27
  • MNMD N/A
  • 52 Week Low
  • ITIC $185.00
  • MNMD $4.70
  • 52 Week High
  • ITIC $290.40
  • MNMD $10.44
  • Technical
  • Relative Strength Index (RSI)
  • ITIC 44.97
  • MNMD 69.04
  • Support Level
  • ITIC $200.78
  • MNMD $6.95
  • Resistance Level
  • ITIC $215.27
  • MNMD $7.29
  • Average True Range (ATR)
  • ITIC 6.06
  • MNMD 0.35
  • MACD
  • ITIC -0.06
  • MNMD 0.16
  • Stochastic Oscillator
  • ITIC 26.30
  • MNMD 95.17

About ITIC Investors Title Company

Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

Share on Social Networks: